Dogecoin Cash, Inc. (CBDS) Announces Its Previously Declared Stock Dividend Distribution Has Been Finalized

March 10, 2025 – Mesquite, NV – Dogecoin Cash, Inc. ($CBDS), a publicly traded leader in blockchain innovation, is excited to announce its strategic expansion into the rapidly growing meme coin

MESQUITE, NV —

March 10, — Mesquite, NV – Dogecoin Cash, Inc. ($CBDS), a publicly traded company known for its role in advancing blockchain technology, is excited to announce its strategic expansion into the rapidly growing meme coin sector.

Dogecoin Cash, Inc. (OTCQB:CBDS) today announced that the Financial Industry Regulatory Authority (FINRA) has published a new Daily List entry for the Company's previously declared stock dividend. The payment date for this dividend is now set for May 9, 2025, and the record date remains November 25, 2024, as originally announced. The dividend will consist of one (1) share of Series A Preferred Stock of the issuer for every 1,000 shares of common stock held on the record date.

This preferred stock is not convertible but may be redeemed by the Company at its discretion on or before October 25, 2034, at a rate of ten (10) shares of common stock for each preferred share. The preferred stock carries the right to receive, if and when declared by the Board of Directors, one (1) share of common stock annually per preferred share, provided the holder is of record as of November 25 of the applicable year.

The symbol for Dogecoin Cash, Inc. common stock will remain CBDS until a new symbol is applied for. A trading symbol for the preferred shares has not yet been assigned. FINRA has indicated that no ex-dividend date will be established for this event.

Fractional shares will be rounded up to one whole share.

About Dogecoin Cash, Inc. (CBDS)

Dogecoin Cash, Inc. (OTCQB: CBDS) is a publicly traded company that owns and operates PrestoDoctor, a trusted leader in medical cannabis telemedicine. CBDS holds the first patented cannabis strain, Ecuadorian Sativa aka “CTA”, and a patented cannabis lozenge for treatment of hypertension. CBDS engages in cannabis product development and licensing, as well as blockchain innovation. The company is actively engaged in leveraging emerging digital assets, decentralized finance (DeFi) solutions, and blockchain technology to enhance its offerings and create new market opportunities.

Dogecoin Cash, Inc., and the DogeCoin Cash (DOG) token were inspired by the well-known cryptocurrency Dogecoin (DOGE); however, Dogecoin Cash, Inc. is not affiliated with, endorsed by, or associated with Dogecoin or its development team.